Skip to Content

WATSON 835 3.75 (Clorazepate Dipotassium 3.75 mg)

Pill with imprint WATSON 835 3.75 is Blue, Five-sided and has been identified as Clorazepate Dipotassium 3.75 mg. It is supplied by Watson Laboratories, Inc..

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 835 3.75

Clorazepate Dipotassium

Imprint
WATSON 835 3.75
Strength
3.75 mg
Color
Blue
Shape
Five-sided
Availability
Prescription only
Drug Class
Benzodiazepines
Pregnancy Category
N - Not classified
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
52544-0835

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.